ALPS Medical Breakthroughs ETF
Save
About
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.
Biggest holdings
Health care
5.19%
Health care
4.88%
Health care
4.54%
Health care
4.07%
Health care
2.68%
Health care
2.54%
Health care
2.29%
Health care
2.28%
Health care
2.16%
Health care
2.06%
Similar securities
Based on sector and market capitalization
Report issue